PLX · Protalix BioTherapeutics, Inc. · Proposed Sales
$2.71
+0.00 (+0.00%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$219.15M
Shares
80.57M
Volume · Oct 5
984.06K
Avg daily vol (3M)
720.45K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.